Baylor Institute of Transplant Sciences

Dallas, Texas 75246

0 studies enrolling now · 1 studies all time

What they study most

Graft-Versus-Host Disease

Studies at this site

• Trial for Evaluation of Safety of Escalating Dose Levels of MEDI-507 in Patients for Treatment of at Least Grade II Graft-Versus-Host Disease (GvHD) — Completed